Looking for Cholesterol Excipient pharmaceutical excipients? Find information on Cholesterol Excipient's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

SUPPLIERS

read-more
read-more

01

Nippon Fine Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

2024 ACI Convention
Not Confirmed
arrow

Nippon Fine Chemical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
2024 ACI Convention
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

Xiamen SINOPEG Biotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

2024 ACI Convention
Not Confirmed
arrow

Xiamen SINOPEG Biotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
2024 ACI Convention
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

2024 ACI Convention
Not Confirmed

02

2024 ACI Convention
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDF DOSSIERS SUPPLIERS

read-more
read-more

01

arrow
2024 ACI Convention
Not Confirmed
U.S.A
arrow
2024 ACI Convention
Not Confirmed

VINCRISTINE SULFATE

Drug : MARQIBO KIT

Dosage Form : INJECTABLE, LIPOSOMAL; INTRAVENOUS

Application Number : 202497

Country : US

Patented : No

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXORUBICIN HYDROCHLORIDE

Drug : DOXIL (LIPOSOMAL)

Dosage Form : INJECTABLE, LIPOSOMAL; INJECTION

Application Number : 50718

Country : US

Patented : No

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

HYDROCORTISONE

Drug : HYDROCORTISONE

Dosage Form : LOTION; TOPICAL

Application Number : 40417

Country : US

Patented : No

blank

04

arrow
2024 ACI Convention
Not Confirmed
France
arrow
2024 ACI Convention
Not Confirmed

IRINOTECAN HYDROCHLORIDE

Drug : ONIVYDE

Dosage Form : INJECTABLE, LIPOSOMAL; INTRAVENOUS

Application Number : 207793

Country : US

Patented : Yes

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 200221

Country : US

Patented : No

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

CYTARABINE

Drug : DEPOCYT

Dosage Form : INJECTABLE, LIPOSOMAL; INJECTION

Application Number : 21041

Country : US

Patented : No

blank

07

arrow
2024 ACI Convention
Not Confirmed
U.S.A
arrow
2024 ACI Convention
Not Confirmed

HYDROCORTISONE

Drug : HYDROCORTISONE

Dosage Form : CREAM; TOPICAL

Application Number : 40879

Country : US

Patented : No

blank

08

arrow
2024 ACI Convention
Not Confirmed
India
arrow
2024 ACI Convention
Not Confirmed

DOXORUBICIN HYDROCHLORIDE

Drug : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

Dosage Form : INJECTABLE, LIPOSOMAL; INJECTION

Application Number : 203263

Country : US

Patented : No

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty